乳腺癌组织中黑色素瘤缺乏因子2的表达及其临床意义

Expression of absent in melanoma 2 in breast cancer and its clinical significance

  • 摘要:
    目的 探讨乳腺癌组织中黑色素瘤缺乏因子2(AIM2)的表达及其临床意义。
    方法 选择乳腺癌患者118对癌组织及癌旁组织, 采用免疫组化方法检测癌组织及癌旁组织中AIM2的表达,分析癌组织中AIM2表达与临床病理特征的关系。采用Kaplan-Meier生存曲线分析AIM2蛋白与乳腺癌患者生存期的关系; 采用COX回归分析探讨乳腺癌患者无瘤生存期及总生存期的影响因素。
    结果 乳腺癌组织中AIM2阳性率低于癌旁组织,差异有统计学意义(P < 0.05);乳腺癌组织免疫组化评分低于癌旁组织,差异有统计学意义(P < 0.05);癌组织中AIM2表达与肿瘤直径、淋巴结转移、临床分期和脉管内癌栓相关(P < 0.05);Kaplan-Meier分析结果表明,乳腺癌组织中AIM2低表达患者有更短的总生存期及无瘤生存期(χ2=9.072、6.101, P=0.004、0.015);多因素Cox回归分析显示, AIM2(OR=3.387, 95%CI: 1.033~21.440, P=0.047)是乳腺癌患者无瘤生存期的独立影响因素。
    结论 AIM2在乳腺癌组织中低表达,提示乳腺癌患者预后不良。

     

    Abstract:
    Objective To investigate the expression and clinical significance of absent in melanoma 2 (AIM2) in breast cancer tissues.
    Methods A total of 118 pairs of cancer tissues and adjacent tissues from breast cancer patients were selected. Immunohistochemistry was used to detect the expression of AIM2 in cancer tissues and adjacent tissues, the relationships between AIM2 expression in cancer tissues and clinicopathological characteristics were analyzed. Kaplan-Meier survival curve was used to analyze the relationship between AIM2 protein and survival of breast cancer patients; COX regression analysis was used to explore the influencing factors of tumor-free survival and overall survival of breast cancer patients.
    Results The positive rate of AIM2 in breast cancer tissues was lower than that in adjacent tissues, and the difference was statistically significant (P < 0.05); the immunohistochemical score of breast cancer tissue was lower than that of adjacent tissue, and the difference was statistically significant (P < 0.05); the expression of AIM2 in cancer tissue was correlated with tumor diameter, lymph node metastasis, clinical stage and intravascular tumor thrombus (P < 0.05); Kaplan-Meier analysis showed that patients with low AIM2 expression in breast cancer tissue had shorter overall survival and disease-free survival (χ2=9.072, 6.101; P=0.004, 0.015); COX multivariate regression analysis showed that AIM2 (OR=3.387; 95%CI, 1.033 to 21.440; P=0.047) was an independent influencing factor of tumor-free survival in breast cancer patients.
    Conclusion AIM2 is lowly expressed in breast cancer tissues, and it suggests that the prognosis of breast cancer patients is poor.

     

/

返回文章
返回